SESN2 and melanoma: In contrast to Sestrins’ recognised tumour-suppressive function across multiple tissues, SESN2 frequently shows elevated expression in various skin cancers, including melanomas and squamous cell carcinomas, acting as an oncogene to promote skin carcinogenesis [31].